Working in an ethical and transparent way is a priority for the team at GSK.
We are transparent about our relationships with healthcare professionals to help address community concerns about how the pharmaceutical industry and healthcare providers work together to advance patient care.
In 2010 we became the first pharmaceutical company in New Zealand to disclose how much we pay healthcare professionals for services such as consulting, speaking at meetings, and attending academic meetings and conferences.
The figure we disclose each year is an aggregate figure, and does not include payments made to publicly- and privately-funded groups for conducting research and development or clinical trial projects.
Recently, we chose to further our commitment to working in ethical and transparent ways by announcing that we will cease these payments altogether by 2016. Until this time, we will continue to disclose the sums we pay healthcare professionals for the above services.
|Individual Attendance at conferences and congresses including speakers||$19,583||$61,154.64||$177,076.26|
|Payments to HCOs||$113,226||$105,247||$68,615|